MMRJ Cover Page

Multidisciplinary Multilingual Research Journal

eISSN : 3107-8141 | Frequency: Quarterly

Editor in Chief : Prof. (Dr.) Anand Mittal

About : Multidisciplinary Multilingual Research Journal is a national, quarterly, peer-reviewed academic publication that seeks to foster inclusive, cross-disciplinary dialogue and promote scholarly excellence across linguistic and cultural boundaries. Published by Nitee Publications, the journal is committ Read more

Article Metrics
Views : 227 | Downloads: 320
Crossref Citations: Loading...

View in Google Scholar
Dimensions
Altmetric Attention
PlumX:

Examining Perceptions of Supply Chain Vulnerability in the Indian Pharmaceutical Industry: With Special Reference to Regulatory and Financial Risks

  • Syed Shaamikh Ahsan* Syed Shaamikh Ahsan Corresponding author Research Scholar, Department of Management Studies, Jamia Millia Islamia. India ,  
  • Pankaj Kumar Gupta Pankaj Kumar Gupta Professor Department of Management Studies, Jamia Millia Islamia India
Received: January 08, 2026
Accepted: January 30, 2026
Published: February 18, 2026
Volume: 2 (1) | Page: 1-10

Abstract

We investigate the perception on the severity and probability of key regulatory and financial risks within India’s pharmaceutical supply chain, drawing insights from quantitative data and stakeholder perceptions. We assess the perception on eight major supply chain risks – changing domestic regulations, changing international regulations, compliance costs, import tariff changes, export tariff changes, tax payable changes, interest rate changes, exchange rate changes. We have conducted a survey of 151 respondents involved in the supply chain function of Indian Pharma Companies. The results indicate that exchange rate changes emerged as the most critical risk in terms of severity. Import tariff changes emerged as the most probable risk in terms of probability. ANOVA analysis revealed that severity perceptions varied for changing international regulations and export tariff changes; probability perceptions varied for changing international regulations, compliance costs, export tariff changes and tax payable change. Our findings implicate the need for differentiated risk mitigation strategies. By identifying and analysing these vulnerabilities, our study offers actionable insights for pharmaceutical managers aiming to enhance supply chain resilience, safeguard product quality, and ensure timely delivery in a complex and evolving market landscape.

Keywords: Pharmaceutical supply chain, regulatory and financial risks, export tariff changes

References

  1. Azam, M. K., Hasan, S. M., & Qureshi, S. M. (2023). Exploring the critical success factors of a resilient supply
  2. chain. Engineering Management in Production and Services, 15(1), 41–56. https://doi.org/10.2478/emj2023-0004
  3. Chopra, S., & Meindl, P. (2012). Supply Chain Management. Strategy, Planning & Operation. In Das Summa
  4. Summarum des Management (pp. 265–275). Gabler. https://doi.org/10.1007/978-3-8349-9320-5_22
  5. Emrouznejad, A., Abbasi, S., & Sıcakyüz, Ç. (2023). Supply chain risk management: A content analysis-based
  6. review of existing and emerging topics. Supply Chain Analytics, 3, 100031.
  7. https://doi.org/10.1016/j.sca.2023.100031
  8. Expresspharma. (2025). Key trends in pharma and supply chain management for 2025. Https://Www.Expresspharma.in/Key-Trends-in-Pharma-and-Supply-Chain-Management-for-2025/
  9. Faggioni, F., Valerio Rossi, M., & Sestino, A. (2023). Supply Chain Resilience in the Pharmaceutical Industry: A
  10. Qualitative Analysis from Scholarly and Managerial Perspectives. International Journal of Business and
  11. Management, 18(1), 129. https://doi.org/10.5539/ijbm.v18n1p129
  12. Feeney, A. J., Goad, J. A., & Flaherty, G. T. (2024). Global perspective of the risks of falsified and counterfeit
  13. medicines: A critical review of the literature. Travel Medicine and Infectious Disease, 61, 102758.
  14. https://doi.org/10.1016/j.tmaid.2024.102758
  15. Ganguly, A., & Kumar, C. (2019). Evaluating Supply Chain Resiliency Strategies In The Indian Pharmaceutical
  16. Sector: A Fuzzy Analytic Hierarchy Process (F-Ahp) Approach. International Journal of the Analytic
  17. Hierarchy Process, 11(2), 153–180. https://doi.org/10.13033/ijahp.v11i2.620
  18. Gera, N., & Singh, R. (2025). Identifying key drivers of supply chain resilience in Indian pharmaceutical industry
  19. for enhanced export performance. International Journal of Pharmaceutical and Healthcare Marketing.
  20. https://doi.org/10.1108/IJPHM-09-2024-0093
  21. Gupta, H., & Kayande, R. A. (2023). Enhancing Pharmaceutical Supply Chain Resilience: A Study of
  22. Pharmaceutical Companies in Multiple Geographies. Indian Journal of Pharmaceutical Education and
  23. Research, 57(2), 603–611. https://doi.org/10.5530/ijper.57.2.74
  24. IBEF. (2025). Pharmaceuticals-Infographic-May-2025.
  25. https://Www.Ibef.Org/Uploads/Industry/Infrographics/Large/Pharmaceuticals-Infographic-May2025.Pdf.
  26. Jaberidoost, M., Olfat, L., Hosseini, A., Kebriaeezadeh, A., Abdollahi, M., Alaeddini, M., & Dinarvand, R. (2015).
  27. Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple
  28. additive weighting (SAW) methods. Journal of Pharmaceutical Policy and Practice, 8(1), 9.
  29. https://doi.org/10.1186/s40545-015-0029-3
  30. KPMG. (2025). Third-party risks in the pharmaceutical supply chain.
  31. Https://Kpmg.Com/in/En/Insights/2025/03/Third-Party-Risks-in-the-Pharmaceutical-SupplyChain.Html
  32. Kumar, S., & Anbanandam, R. (2020). Impact of risk management culture on supply chain resilience: An
  33. empirical study from Indian manufacturing industry. Proceedings of the Institution of Mechanical
  34. Engineers, Part O: Journal of Risk and Reliability, 234(2), 246–259.
  35. https://doi.org/10.1177/1748006X19886718
  36. Lima, M. B. A., & Yonamine, M. (2023). Counterfeit medicines: relevance, consequences and strategies to combat
  37. the global crisis. Brazilian Journal of Pharmaceutical Sciences, 59. https://doi.org/10.1590/s2175-
  38. 97902023e20402
  39. Merkuryeva, G., Valberga, A., & Smirnov, A. (2019). Demand forecasting in pharmaceutical supply chains: A
  40. case study. Procedia Computer Science, 149, 3–10. https://doi.org/10.1016/j.procs.2019.01.100
  41. Mishra, R., Ramesh, D., Mohammad, N., & Mondal, B. (2024). Blockchain enabled secure pharmaceutical supply
  42. chain framework with traceability: an efficient searchable pharmachain approach. Cluster Computing,
  43. 27(10), 13621–13641. https://doi.org/10.1007/s10586-024-04626-w
  44. Mordorintelligence. (2025, June 23). India Pharmaceutical Market Analysis - Industry Growth, Size & Forecast
  45. Report (2025 - 2030). Https://Www.Mordorintelligence.Com/Industry-Reports/PharmaceuticalsIndustry-in-India
  46. Özdoğan, G. C., & Mulgan, S. (2024). The Role of Logistics in Healthcare and Well-Being (pp. 23–48).
  47. https://doi.org/10.4018/979-8-3693-7071-1.ch002
  48. Pathy, S. R., & Rahimian, H. (2023). A resilient inventory management of pharmaceutical supply chains under
  49. demand disruption. Computers & Industrial Engineering, 180, 109243.
  50. https://doi.org/10.1016/j.cie.2023.109243
  51. Sangode, P. B. (2024). Developing A Framework for The Indian Pharmaceutical Supply Chain Risks Assessment
  52. through FMEA Approach. Asia Pacific Journal of Health Management, 19(3).
  53. https://doi.org/10.24083/apjhm.v19i3.3171
  54. Sharma, A., Kumar, D., & Arora, N. (2024). Supply chain risk factor assessment of Indian pharmaceutical industry
  55. for performance improvement. International Journal of Productivity and Performance Management,
  56. 73(1), 119–157. https://doi.org/10.1108/IJPPM-01-2022-0035
  57. Shukla, M., & Jharkharia, S. (2013). Agri‐fresh produce supply chain management: a state‐of‐the‐art literature
  58. review. International Journal of Operations & Production Management, 33(2), 114–158.
  59. https://doi.org/10.1108/01443571311295608
  60. Skyes, C. (2018). Time- and Temperature-Controlled Transport: Supply Chain Challenges and Solutions. P T.,
  61. 43(3), 154–170.
  62. Syed, I. U., & Milburn, T. W. (2024). Rethinking counterfeit medical supply chains: A critical review of the current
  63. literature. Health Care Science, 3(3), 203–210. https://doi.org/10.1002/hcs2.97
  64. Vishwakarma, V., Prakash, C., & Barua, M. K. (2016). A fuzzy-based multi criteria decision making approach for
  65. supply chain risk assessment in Indian pharmaceutical industry. International Journal of Logistics
  66. Systems and Management, 25(2), 245. https://doi.org/10.1504/IJLSM.2016.078915
  67. Wahab, S. N., Ahmed, N., & Ab Talib, M. S. (2024). An overview of the SWOT analysis in India’s
  68. pharmaceutical supply chain. Arab Gulf Journal of Scientific Research, 42(3), 771–787.
  69. https://doi.org/10.1108/AGJSR-03-2023-0102
Recently Cited By
Loading citations...
Citation copied to clipboard
×
Cite this Article